AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 286: H2089-H2095, 2004. First published January 15, 2004; doi:10.1152/ajpheart.00582.2003
0363-6135/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/H2089    most recent
00582.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roman, B. B.
Right arrow Articles by Buttrick, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roman, B. B.
Right arrow Articles by Buttrick, P. M.

Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo

Brian B. Roman, Paul H. Goldspink, Elyse Spaite, Dalia Urboniene, Ron McKinney, David L. Geenen, R. John Solaro, and Peter M. Buttrick

Center for Cardiovascular Sciences, Department of Medicine, Section of Cardiology, and Department of Physiology and Biophysics, University of Illinois, Chicago, Illinois 60612

Submitted 20 June 2003 ; accepted in final form 12 January 2004

Protein kinase C (PKC) modulates cardiomyocyte function by phosphorylation of intracellular targets including myofilament proteins. Data generated from studies on in vitro heart preparations indicate that PKC phosphorylation of troponin I (TnI), primarily via PKC-{epsilon}, may slow the rates of cardiac contraction and relaxation (+dP/dt and –dP/dt). To explore this issue in vivo, we employed transgenic mice [mutant TnI (mTnI) mice] in which the major PKC phosphorylation sites on cardiac TnI were mutated by alanine substitutions for Ser43 and Ser45 and studied in situ hemodynamics at baseline and increased inotropy. Hearts from mTnI mice exhibited increased contractility, as shown by a 30% greater +dP/dt and 18% greater –dP/dt than FVB hearts, and had a negligible response to isoproterenol compared with FVB mice, in which +dP/dt increased by 33% and –dP/dt increased by 26%. Treatment with phenylephrine and propranolol gave a similar result; FVB mouse hearts demonstrated a 20% increase in developed pressure, whereas mTnI mice showed no response. Back phosphorylation of TnI from mTnI hearts demonstrated that the mutation of the PKC sites was associated with an enhanced PKA-dependent phosphorylation independent of a change in basal cAMP levels. Our results demonstrate the important role that PKC-dependent phosphorylation of TnI has on the modulation of cardiac function under basal as well as augmented states and indicate interdependence of the phosphorylation sites of TnI in hearts beating in situ.

troponin; protein kinase C; contractility; mouse



Address for reprint requests and other correspondence: B. B. Roman, Section of Cardiology, 840 S. Wood St. (M/C 715), Chicago, IL 60612 (E-mail: broman{at}uic.edu).




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-F. Lai, Y.-Z. Chen, L.-P. Feng, X.-M. Meng, J.-F. Ding, L.-Y. Wang, J. Ye, P. Li, X.-S. Cheng, Y. Kitamoto, et al.
Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H708 - H716.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. M. Samarel
PICOT: A Multidomain Scaffolding Inhibitor of Hypertrophic Signal Transduction
Circ. Res., March 28, 2008; 102(6): 625 - 627.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. J. Belin, M. P. Sumandea, E. J. Allen, K. Schoenfelt, H. Wang, R. J. Solaro, and P. P. de Tombe
Augmented Protein Kinase C-{alpha}-Induced Myofilament Protein Phosphorylation Contributes to Myofilament Dysfunction in Experimental Congestive Heart Failure
Circ. Res., July 20, 2007; 101(2): 195 - 204.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Jeong, H. Cha, E. Kim, M. Kang, D. K. Yang, J. M. Kim, P. O. Yoon, J. G. Oh, O. Y. Bernecker, S. Sakata, et al.
PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility
Circ. Res., August 4, 2006; 99(3): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. A. MacGowan, J. Rager, S. G. Shroff, and M. A. Mathier
In vivo {alpha}-adrenergic responses and troponin I phosphorylation: anesthesia interactions
J Appl Physiol, April 1, 2005; 98(4): 1163 - 1170.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.